{"count": 110, "results": [{"_id": "33811249", "pmid": 33811249, "pmcid": "PMC8018962", "title": "Metformin prevents stroke damage in non-diabetic female mice with chronic kidney disease", "journal": "Sci Rep", "authors": ["Grissi M", "Boudot C", "Assem M", "Candellier A", "Lando M", "Poirot-Leclercq S", "Boullier A", "Bennis Y", "Lenglet G", "Avondo C", "Lalau JD", "Choukroun G", "Massy ZA", "Kamel S", "Chillon JM", "Hénaut L"], "date": "2021-04-02T00:00:00Z", "doi": "10.1038/s41598-021-86905-9", "meta_date_publication": "2021 Apr 2", "meta_volume": "11", "meta_issue": "1", "meta_pages": "7464", "score": 50271.188, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ prevents @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke damage@@@ in non-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ female @SPECIES_10090 @@@mice@@@ with @DISEASE_Renal_Insufficiency_Chronic @DISEASE_MESH:D051436 @@@chronic kidney disease@@@", "citations": {"NLM": "Grissi M, Boudot C, Assem M, Candellier A, Lando M, Poirot-Leclercq S, Boullier A, Bennis Y, Lenglet G, Avondo C, Lalau JD, Choukroun G, Massy ZA, Kamel S, Chillon JM, Hénaut L. Metformin prevents stroke damage in non-diabetic female mice with chronic kidney disease Sci Rep. 2021 Apr 2;11(1):7464. PMID: 33811249", "BibTeX": "@article{33811249, title={Metformin prevents stroke damage in non-diabetic female mice with chronic kidney disease}, author={Grissi M and Boudot C and Assem M and Candellier A and Lando M and Poirot-Leclercq S and Boullier A and Bennis Y and Lenglet G and Avondo C and Lalau JD and Choukroun G and Massy ZA and Kamel S and Chillon JM and Hénaut L}, journal={Sci Rep}, volume={11}, number={1}, pages={7464}}"}}, {"_id": "36841981", "pmid": 36841981, "title": "The Effect of Metformin on Vitamin B12 Deficiency and Stroke.", "journal": "Isr Med Assoc J", "authors": ["Horrany N", "Abu Dahoud W", "Moallem Y", "Hajouj T", "Zreik M", "Blum A"], "date": "2023-02-01T00:00:00Z", "meta_date_publication": "2023 Feb", "meta_volume": "25", "meta_issue": "2", "meta_pages": "122-125", "score": 50267.11, "text_hl": "The Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ on Vitamin B12 Deficiency and @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@Stroke@@@.", "citations": {"NLM": "Horrany N, Abu Dahoud W, Moallem Y, Hajouj T, Zreik M, Blum A. The Effect of Metformin on Vitamin B12 Deficiency and Stroke. Isr Med Assoc J. 2023 Feb;25(2):122-125. PMID: 36841981", "BibTeX": "@article{36841981, title={The Effect of Metformin on Vitamin B12 Deficiency and Stroke.}, author={Horrany N and Abu Dahoud W and Moallem Y and Hajouj T and Zreik M and Blum A}, journal={Isr Med Assoc J}, volume={25}, number={2}, pages={122-125}}"}}, {"_id": "33915857", "pmid": 33915857, "pmcid": "PMC8066143", "title": "Evaluation of the Effectiveness of Post-Stroke Metformin Treatment Using Permanent Middle Cerebral Artery Occlusion in Rats", "journal": "Pharmaceuticals (Basel)", "authors": ["Zemgulyte G", "Tanaka S", "Hide I", "Sakai N", "Pampuscenko K", "Borutaite V", "Rastenyte D"], "date": "2021-04-01T00:00:00Z", "doi": "10.3390/ph14040312", "meta_date_publication": "2021 Apr 1", "meta_volume": "14", "meta_issue": "4", "meta_pages": "", "score": 50264.266, "text_hl": "Evaluation of the Effectiveness of @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@Post-Stroke@@@ @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Treatment Using Permanent Middle @DISEASE_Arterial_Occlusive_Diseases @DISEASE_MESH:D001157 @@@Cerebral Artery Occlusion@@@ in Rats", "citations": {"NLM": "Zemgulyte G, Tanaka S, Hide I, Sakai N, Pampuscenko K, Borutaite V, Rastenyte D. Evaluation of the Effectiveness of Post-Stroke Metformin Treatment Using Permanent Middle Cerebral Artery Occlusion in Rats Pharmaceuticals (Basel). 2021 Apr 1;14(4):. PMID: 33915857", "BibTeX": "@article{33915857, title={Evaluation of the Effectiveness of Post-Stroke Metformin Treatment Using Permanent Middle Cerebral Artery Occlusion in Rats}, author={Zemgulyte G and Tanaka S and Hide I and Sakai N and Pampuscenko K and Borutaite V and Rastenyte D}, journal={Pharmaceuticals (Basel)}, volume={14}, number={4}}"}}, {"_id": "36408248", "pmid": 36408248, "pmcid": "PMC9669075", "title": "Neuropharmacological efficacy of metformin for stroke in rodents: A meta-analysis of preclinical trials", "journal": "Front Pharmacol", "authors": ["Fu W", "Tang Y", "Che X", "Tan J", "Ma Y", "He Z"], "date": "2022-11-03T00:00:00Z", "doi": "10.3389/fphar.2022.1009169", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "1009169", "score": 50264.0, "text_hl": "Neuropharmacological efficacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ in rodents: A meta-analysis of preclinical trials", "citations": {"NLM": "Fu W, Tang Y, Che X, Tan J, Ma Y, He Z. Neuropharmacological efficacy of metformin for stroke in rodents: A meta-analysis of preclinical trials Front Pharmacol. 2022;13():1009169. PMID: 36408248", "BibTeX": "@article{36408248, title={Neuropharmacological efficacy of metformin for stroke in rodents: A meta-analysis of preclinical trials}, author={Fu W and Tang Y and Che X and Tan J and Ma Y and He Z}, journal={Front Pharmacol}, volume={13}, pages={1009169}}"}}, {"_id": "32601121", "pmid": 32601121, "title": "Association of prestroke metformin use, stroke severity, and thrombolysis outcome.", "journal": "Neurology", "authors": ["Westphal LP", "Widmer R", "Held U", "Steigmiller K", "Hametner C", "Ringleb P", "Curtze S", "Martinez-Majander N", "Tiainen M", "Nolte CH", "Scheitz JF", "Erdur H", "Polymeris AA", "Traenka C", "Eskandari A", "Michel P", "Heldner MR", "Arnold M", "Zini A", "Vandelli L", "Coutinho JM", "Groot AE", "Padjen V", "Jovanovic DR", "Bejot Y", "Brenière C", "Turc G", "Seners P", "Pezzini A", "Magoni M", "Leys D", "Gilliot S", "Scherrer MJ", "Kägi G", "Luft AR", "Gensicke H", "Nederkoorn P", "Tatlisumak T", "Engelter ST", "Wegener S", "Thrombolysis in Ischemic Stroke Patients (TRISP) Study Group"], "date": "2020-07-28T00:00:00Z", "doi": "10.1212/WNL.0000000000009951", "meta_date_publication": "2020 Jul 28", "meta_volume": "95", "meta_issue": "4", "meta_pages": "e362-e373", "score": 50262.934, "text_hl": "Association of prestroke @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use, @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ severity, and thrombolysis outcome.", "citations": {"NLM": "Westphal LP, Widmer R, Held U, Steigmiller K, Hametner C, Ringleb P, Curtze S, Martinez-Majander N, Tiainen M, Nolte CH, Scheitz JF, Erdur H, Polymeris AA, Traenka C, Eskandari A, Michel P, Heldner MR, Arnold M, Zini A, Vandelli L, Coutinho JM, Groot AE, Padjen V, Jovanovic DR, Bejot Y, Brenière C, Turc G, Seners P, Pezzini A, Magoni M, Leys D, Gilliot S, Scherrer MJ, Kägi G, Luft AR, Gensicke H, Nederkoorn P, Tatlisumak T, Engelter ST, Wegener S, Thrombolysis in Ischemic Stroke Patients (TRISP) Study Group. Association of prestroke metformin use, stroke severity, and thrombolysis outcome. Neurology. 2020 Jul 28;95(4):e362-e373. PMID: 32601121", "BibTeX": "@article{32601121, title={Association of prestroke metformin use, stroke severity, and thrombolysis outcome.}, author={Westphal LP and Widmer R and Held U and Steigmiller K and Hametner C and Ringleb P and Curtze S and Martinez-Majander N and Tiainen M and Nolte CH and Scheitz JF and Erdur H and Polymeris AA and Traenka C and Eskandari A and Michel P and Heldner MR and Arnold M and Zini A and Vandelli L and Coutinho JM and Groot AE and Padjen V and Jovanovic DR and Bejot Y and Brenière C and Turc G and Seners P and Pezzini A and Magoni M and Leys D and Gilliot S and Scherrer MJ and Kägi G and Luft AR and Gensicke H and Nederkoorn P and Tatlisumak T and Engelter ST and Wegener S and Thrombolysis in Ischemic Stroke Patients (TRISP) Study Group}, journal={Neurology}, volume={95}, number={4}, pages={e362-e373}}"}}, {"_id": "37051071", "pmid": 37051071, "pmcid": "PMC10084537", "title": "Metformin adherence and the risk of cardiovascular disease: a population-based cohort study", "journal": "Ther Adv Chronic Dis", "authors": ["Yu SF", "Hong CT", "Chen WT", "Chan L", "Chien LN"], "date": "2023-04-04T00:00:00Z", "doi": "10.1177/20406223231163115", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "20406223231163115", "score": 50261.953, "text_hl": "Some studies have reported that a @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-containing regimen reduced the risk of @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@   and @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@MI@@@. ", "citations": {"NLM": "Yu SF, Hong CT, Chen WT, Chan L, Chien LN. Metformin adherence and the risk of cardiovascular disease: a population-based cohort study Ther Adv Chronic Dis. 2023;14():20406223231163115. PMID: 37051071", "BibTeX": "@article{37051071, title={Metformin adherence and the risk of cardiovascular disease: a population-based cohort study}, author={Yu SF and Hong CT and Chen WT and Chan L and Chien LN}, journal={Ther Adv Chronic Dis}, volume={14}, pages={20406223231163115}}"}}, {"_id": "35465053", "pmid": 35465053, "pmcid": "PMC9021516", "title": "Metformin use is associated with low risk of case fatality and disability rates in first-ever stroke patients with type 2 diabetes", "journal": "Ther Adv Chronic Dis", "authors": ["Tu WJ", "Liu Z", "Chao BH", "Yan F", "Ma L", "Cao L", "Ji XM", "Wang LD"], "date": "2022-04-19T00:00:00Z", "doi": "10.1177/20406223221076894", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "20406223221076894", "score": 50260.5, "text_hl": "This may reduce the correlation between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ recurrence. ", "citations": {"NLM": "Tu WJ, Liu Z, Chao BH, Yan F, Ma L, Cao L, Ji XM, Wang LD. Metformin use is associated with low risk of case fatality and disability rates in first-ever stroke patients with type 2 diabetes Ther Adv Chronic Dis. 2022;13():20406223221076894. PMID: 35465053", "BibTeX": "@article{35465053, title={Metformin use is associated with low risk of case fatality and disability rates in first-ever stroke patients with type 2 diabetes}, author={Tu WJ and Liu Z and Chao BH and Yan F and Ma L and Cao L and Ji XM and Wang LD}, journal={Ther Adv Chronic Dis}, volume={13}, pages={20406223221076894}}"}}, {"_id": "32702900", "pmid": 32702900, "pmcid": "PMC7373575", "title": "Gliclazide monotherapy increases risks of all-cause mortality and has similar risk of acute myocardial infarction and stroke with glimepiride monotherapy in Korean type 2 diabetes mellitus", "journal": "Medicine (Baltimore)", "authors": ["Cho EH", "Han K", "Kim B", "Lee DH"], "date": "2020-07-17T00:00:00Z", "doi": "10.1097/MD.0000000000021236", "meta_date_publication": "2020 Jul 17", "meta_volume": "99", "meta_issue": "29", "meta_pages": "e21236", "score": 50260.363, "text_hl": "Furthermore, both @SPECIES_9606 @@@men@@@ and @SPECIES_9606 @@@women@@@ exhibited a significantly lower risk of @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group than in other groups. ", "citations": {"NLM": "Cho EH, Han K, Kim B, Lee DH. Gliclazide monotherapy increases risks of all-cause mortality and has similar risk of acute myocardial infarction and stroke with glimepiride monotherapy in Korean type 2 diabetes mellitus Medicine (Baltimore). 2020 Jul 17;99(29):e21236. PMID: 32702900", "BibTeX": "@article{32702900, title={Gliclazide monotherapy increases risks of all-cause mortality and has similar risk of acute myocardial infarction and stroke with glimepiride monotherapy in Korean type 2 diabetes mellitus}, author={Cho EH and Han K and Kim B and Lee DH}, journal={Medicine (Baltimore)}, volume={99}, number={29}, pages={e21236}}"}}, {"_id": "36933522", "pmid": 36933522, "title": "Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes diagnosed after metformin-triggered stroke-like episodes.", "journal": "J Stroke Cerebrovasc Dis", "authors": ["Murakami K", "Sakamoto K", "Ishiguchi H", "Ito H"], "date": "2023-05-01T00:00:00Z", "doi": "10.1016/j.jstrokecerebrovasdis.2023.107080", "meta_date_publication": "2023 May", "meta_volume": "32", "meta_issue": "5", "meta_pages": "107080", "score": 50258.59, "text_hl": "@DISEASE_Mitochondrial_encephalopathy @DISEASE_MESH:C538525 @@@Mitochondrial encephalopathy@@@, @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@, and @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@-like episodes diagnosed after @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-triggered @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@-like episodes.", "citations": {"NLM": "Murakami K, Sakamoto K, Ishiguchi H, Ito H. Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes diagnosed after metformin-triggered stroke-like episodes. J Stroke Cerebrovasc Dis. 2023 May;32(5):107080. PMID: 36933522", "BibTeX": "@article{36933522, title={Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes diagnosed after metformin-triggered stroke-like episodes.}, author={Murakami K and Sakamoto K and Ishiguchi H and Ito H}, journal={J Stroke Cerebrovasc Dis}, volume={32}, number={5}, pages={107080}}"}}, {"_id": "35800435", "pmid": 35800435, "pmcid": "PMC9253272", "title": "Development and Evaluation of Novel Metformin Derivative Metformin Threonate for Brain Ischemia Treatment", "journal": "Front Pharmacol", "authors": ["Zhang G", "Chen S", "Jia J", "Liu C", "Wang W", "Zhang H", "Zhen X"], "date": "2022-06-21T00:00:00Z", "doi": "10.3389/fphar.2022.879690", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "879690", "score": 50257.2, "text_hl": "Consequently, a potential therapeutic application of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ has been proposed. ", "citations": {"NLM": "Zhang G, Chen S, Jia J, Liu C, Wang W, Zhang H, Zhen X. Development and Evaluation of Novel Metformin Derivative Metformin Threonate for Brain Ischemia Treatment Front Pharmacol. 2022;13():879690. PMID: 35800435", "BibTeX": "@article{35800435, title={Development and Evaluation of Novel Metformin Derivative Metformin Threonate for Brain Ischemia Treatment}, author={Zhang G and Chen S and Jia J and Liu C and Wang W and Zhang H and Zhen X}, journal={Front Pharmacol}, volume={13}, pages={879690}}"}}]}